Societe Generale Reaffirms Buy Rating on Sanofi SA (SAN)
Sanofi SA traded down 1.45% on Friday, hitting €68.64. Sanofi SA has a 52-week low of €47.00 and a 52-week high of €69.46. The company has a market cap of €90.450 billion and a price-to-earnings ratio of 14.35.
A number of other firms have also recently commented on SAN. Analysts at AlphaValue reiterated an “add” rating on shares of Sanofi SA in a research note to investors on Thursday. They now have a $102.11 price target on the stock. Separately, analysts at Jefferies Group reiterated a “hold” rating on shares of Sanofi SA in a research note to investors on Friday, October 12th. They now have a $90.91 price target on the stock. Finally, analysts at Bryan Garnier & Cie reiterated a “buy” rating on shares of Sanofi SA in a research note to investors on Wednesday, October 10th. They now have a $102.56 price target on the stock.
Sanofi SA, formerly Sanofi-Aventis, is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients’ needs.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.